学术周报 · IF≥10 或专科旗舰刊
骨科领域文献阅读汇编
2026年第46周 (2026-11-13) | PubMed (NLM) · DeepSeek 中英双语
数据来源: PubMed E-utilities · 影响因子筛选: IF≥10 或专科旗舰刊 · 完整摘要不截断
数据来源: PubMed E-utilities · 影响因子筛选: IF≥10 或专科旗舰刊 · 完整摘要不截断
★本周 Top 10 高影响力文献
Ŧ期刊分布统计
| 期刊 | 篇数 | IF |
|---|---|---|
| Advanced healthcare materials | 2 | IF 11.0 |
| Materials horizons | 2 | IF 11.4 |
| ACS nano | 1 | IF 17.3 |
| Journal of advanced research | 1 | IF 17.1 |
| Science translational medicine | 1 | IF 15.6 |
| Chemical reviews | 1 | IF 64.2 |
| Clinical orthopaedics and related research | 1 | IF 4.3 |
| The American journal of sports medicine | 1 | IF 5.4 |
| Biosensors & bioelectronics | 1 | IF 11.8 |
| Cell death and differentiation | 1 | IF 13.6 |
1骨关节炎/软骨 (5篇)
临床研究 (1篇)
Identifying and addressing mechanical malalignment is an important component of treating symptomatic osteochondral defects with osteochondral allograft (OCA) transplantation. However, little is known about how malalignment influences short- to midterm outcomes after OCA transplantation. To evaluate whether mechanical alignment measurements including the hip-knee-ankle (HKA) angle, lateral distal femoral angle (LDFA), medial proximal tibial angle (MPTA), and joint line convergence angle (JLCA) predict clinically significant outcome achievement, graft failure, and reoperation after OCA transplantation with or without concomitant realignment. Case series; Level of evidence, 4. Patient-reported outcome measures (PROMs) were collected preoperatively and at a minimum 2-year follow-up in patients receiving OCA from 2005 to 2023. PROMs included the International Knee Documentation Committee score and Knee injury and Osteoarthritis Outcome Score subscales. Clinically significant outcome thresholds were the minimal clinically important difference (MCID), substantial clinical benefit (SCB), and Patient Acceptable Symptom State (PASS). Preoperative full-length, weightbearing radiographs were used to measure the HKA angle, LDFA, MPTA, and JLCA. Multivariable logistic regression was used for clinically significant outcome achievement and all-cause reoperation; failure and arthroplasty were summarized descriptively because of the low number of events. A total of 66 patients (mean age, 34.1 ± 11.5 years; mean body mass index, 27.8 ± 4.8 kg/m2; 50% female) met inclusion criteria. Mean alignment measurements were 1.8°± 4.0° for the HKA angle, 86.8°± 2.3° for the LDFA, 86.3°± 2.3° for the MPTA, and 1.7°± 1.0° for the JLCA. Although PROMs improved at the final follow-up, no preoperative alignment measure was statistically associated with MCID, PASS, or SCB achievement or with all-cause reoperation (P > .05). In total, 25 (37.9%) patients underwent reoperation; graft survivorship was 93.9%, with 4 failures and 3 arthroplasty conversions. In an exploratory subanalysis, 16 patients with an HKA angle >5° of varus or valgus (13 with concomitant realignment) did not have significantly different rates of reoperation (43.8% vs 36.0%; P = .768) or graft failure (6.3% vs 6.0%; P > .999) compared to their remaining counterparts. In this small, heterogeneous cohort, preoperative mechanical alignment measures were not statistically associated with clinically significant outcome achievement or all-cause reoperation after OCA transplantation. These hypothesis-generating findings do not establish the absence of an alignment effect or define a threshold for realignment because most patients with severe preoperative malalignment underwent concomitant realignment, which may have contributed to the favorable overall outcomes, and failure events were infrequent.
中文摘要:识别和处理机械性力线不良是治疗症状性骨软骨缺损并进行骨软骨同种异体移植(OCA)的重要组成部分。然而,关于力线不良如何影响 OCA 移植后短中期的结果知之甚少。本研究旨在评估包括髋膝踝(HKA)角、外侧远端股骨角(LDFA)、内侧近端胫骨角(MPTA)和关节线收敛角(JLCA)在内的机械性力线测量指标,是否能预测伴有或不伴有同期矫正手术的 OCA 移植后获得临床显著结果、移植物失败及再次手术的风险。本研究为病例系列研究,证据等级为 4 级。收集了 2005 年至 2023 年接受 OCA 治疗的患者在术前及至少 2 年随访时的患者报告结局指标(PROMs)。PROMs 包括国际膝关节文献委员会评分和膝关节损伤与骨关节炎结果评分子量表。临床显著结果的阈值定义为最小临床重要差异(MCID)、实质性临床获益(SCB)和患者可接受症状状态(PASS)。使用术前全长负重 X 线片测量 HKA 角、LDFA、MPTA 和 JLCA。采用多变量逻辑回归分析临床显著结果获得率和全因再次手术;由于事件发生率低,对失败率和关节置换术进行描述性总结。共有 66 名患者(平均年龄 34.1 ± 11.5 岁;平均体重指数 27.8 ± 4.8 kg/m²;女性占 50%)符合纳入标准。平均力线测量结果为:HKA 角 1.8°± 4.0°,LDFA 86.8°± 2.3°,MPTA 86.3°± 2.3°,JLCA 1.7°± 1.0°。尽管最终随访时 PROMs 有所改善,但术前任何力线测量指标与 MCID、PASS 或 SCB 的获得以及全因再次手术均无统计学关联(P > .05)。共有 25 名患者(37.9%)接受了再次手术;移植物存活率为 93.9%,其中 4 例失败,3 例转为关节置换术。在探索性亚组分析中,HKA 角存在 >5° 内翻或外翻的 16 名患者(其中 13 名接受了同期矫正手术)与其余对照患者相比,再次手术率(43.8% vs 36.0%;P = .768)和移植物失败率(6.3% vs 6.0%;P > .999)均无显著差异。在这个小型且异质性较强的队列中,术前机械性力线测量指标与 OCA 移植后获得临床显著结果或全因再次手术无统计学关联。这些生成假设的发现并未确立力线效应的缺失或定义矫正手术的阈值,因为大多数术前存在严重力线不良的患者接受了同期矫正手术,这可能有助于整体良好的结果,且失败事件发生频率较低。
基础研究 (4篇)
Osteoarthritis (OA) involves chondrocyte stress and disrupted intercellular communication, but the proteins associated with synovial fluid-derived exosomes remain incompletely defined. We investigated periostin regulation in chondrocyte models and cellular responses relevant to OA following exposure to periostin-rich exosomes. Exosomes isolated from synovial fluid samples from 15 patients with OA and 5 healthy volunteers (K-L grade 0) were analyzed using label-free proteomics. Human cartilage single-cell transcriptomic data, chondrocyte stress and serial-passage models, promoter-reporter assays, co-immunoprecipitation, protein-turnover assays, RNA sequencing, pathway-inhibition experiments, and destabilization of the medial meniscus (DMM) studies were used for follow-up. Exploratory proteomics identified periostin as a candidate protein, whose abundance was also elevated in models associated with chondrocyte senescence. CEBPB increased periostin expression and POSTN promoter-reporter activity. RACK1 co-precipitated with periostin; RACK1 overexpression slowed periostin degradation and reduced its ubiquitination. Periostin-rich exosomes increased chondrocyte catabolic activity and senescence-associated changes, increased macrophage inflammatory markers, and increased endothelial cell migration and tube formation in vitro. In DMM mice, intra-articular delivery of short hairpin RNA (shRNA) constructs targeting Cebpb or Rack1 reduced cartilage damage, whereas periostin-rich exosome supplementation partially attenuated these effects. Representative joint-tissue immunoblots showed lower CEBPB or RACK1 expression in the corresponding shRNA groups and higher periostin abundance following exosome supplementation. A p38 inhibitor or a MEK/ERK inhibitor partially attenuated chondrocyte responses to exosome treatment. CEBPB promotes periostin expression, whereas RACK1 increases periostin protein stability and contributes to p38/ERK-associated responses to periostin-rich exosomes in chondrocyte models. Intra-articular targeting of Cebpb or Rack1 reduced cartilage damage in DMM mice.
中文摘要:骨关节炎涉及软骨细胞应激和细胞间通讯障碍,但与滑液来源外泌体相关的蛋白质仍未完全明确。我们研究了软骨细胞模型中骨连蛋白的调节机制,以及暴露于富含骨连蛋白的外泌体后与骨关节炎相关的细胞反应。利用无标记蛋白质组学分析了从15名骨关节炎患者和5名健康志愿者(K-L分级0级)滑液样本中分离的外泌体。后续研究采用了人类软骨单细胞转录组数据、软骨细胞应激和连续传代模型、启动子报告基因检测、免疫共沉淀、蛋白质周转分析、RNA测序、通路抑制实验以及内侧半月板不稳定诱导的骨关节炎小鼠模型。探索性蛋白质组学鉴定骨连蛋白为候选蛋白,其在与软骨细胞衰老相关的模型中丰度也升高。CEBPB增加骨连蛋白表达和POSTN启动子报告基因活性。RACK1与骨连蛋白共沉淀;RACK1过表达减缓骨连蛋白降解并降低其泛素化水平。富含骨连蛋白的外泌体在体外增加了软骨细胞的分解代谢活性和衰老相关改变,增加了巨噬细胞炎症标志物,并促进了内皮细胞迁移和管腔形成。在DMM小鼠中,靶向Cebpb或Rack1的短发夹RNA局部关节腔注射减少了软骨损伤,而补充富含骨连蛋白的外泌体部分抵消了这些效应。代表性关节组织免疫印迹显示,相应shRNA组的CEBPB或RACK1表达较低,外泌体补充后骨连蛋白丰度较高。p38抑制剂或MEK/ERK抑制剂部分减弱了软骨细胞对外泌体处理的反应。CEBPB促进骨连蛋白表达,而RACK1增加骨连蛋白稳定性并参与软骨细胞模型中对富含骨连蛋白外泌体的p38/ERK相关反应。局部关节腔靶向Cebpb或Rack1减少了DMM小鼠的软骨损伤。
Osteoarthritis (OA), a leading cause of disability, is characterized by chronic low-grade inflammation and metabolic dysregulation in chondrocytes. TNF-α and IL-1β are key inflammatory drivers in OA pathogenesis, but clinical trials targeting them individually have been unsuccessful, highlighting the potential need for dual-targeting strategies. By screening a US Food and Drug Administration-approved drug library, we identified dabigatran, a thrombin inhibitor, as a potent dual suppressor of TNF-α and IL-1β signaling that restored chondrocyte metabolism. In preclinical OA models, including both mice and cynomolgus macaques, dabigatran attenuated cartilage degeneration, alleviated pain, and improved joint function. To elucidate the molecular mechanisms, we performed biochemical copurification coupled with mass spectrometry, identifying brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2) as a previously unknown dabigatran-binding target. Mechanistically, dabigatran binds to BIG2, promoting BIG2-dependent TNFR1 release to dampen TNF-α signaling while enhancing BIG2-mediated IL-1R1 degradation through the autophagy-lysosome pathway to limit IL-1β effects. These findings establish BIG2-mediated receptor trafficking and membrane dynamics as a regulatory node that concurrently inhibits TNF-α and IL-1β signaling, suggesting this pathway as a potential therapeutic strategy for OA.
中文摘要:骨关节炎(OA)是导致残疾的主要原因,其特征为软骨细胞慢性低度炎症和代谢失调。TNF-α和IL-1β是OA发病机制中的关键炎症驱动因子,但针对它们的单靶点临床试验均未成功,突显了双靶点策略的潜在需求。通过筛选美国食品药品监督管理局批准的药物库,我们鉴定出凝血酶抑制剂达比加群酯(dabigatran)为TNF-α和IL-1β信号的有效双重抑制物,并能恢复软骨细胞代谢。在包括小鼠和食蟹猴在内的临床前OA模型中,达比加群酯减轻了软骨退化,缓解了疼痛并改善了关节功能。为阐明分子机制,我们进行了生化共纯化结合质谱分析,鉴定出 brefeldin A-inhibited guanine nucleotide-exchange protein 2(BIG2)为先前未知的达比加群酯结合靶点。在机制上,达比加群酯与BIG2结合,促进BIG2依赖的TNFR1释放以减弱TNF-α信号,同时通过自噬-溶酶体途径增强BIG2介导的IL-1R1降解以限制IL-1β效应。这些发现确立了BIG2介导的受体运输和膜动力学作为同时抑制TNF-α和IL-1β信号的调节节点,提示该通路可作为OA的潜在治疗策略。
Osteoarthritis (OA) involves alterations in cartilage mechanics, matrix composition, and mineralization, yet in vitro models that resolve remodeling transitions remain limited. Scaffold-free cartilage microtissues derived from human dental pulp stem cells (hDPSCs) are subjected to sequential dynamic rocking culture and triiodothyronine (T3) treatment. Dynamic rocking produces superficial Col I-positive fibrotic and matrix-degrading changes, whereas T3 induces proteoglycan loss, increased Col I and MMP13, irregular mineral deposition, and altered nanomechanical properties, defining a mixed terminal catabolic and mineralizing OA-like state. Transcriptomic profiling shows stage-associated reorganization rather than uniform pathway activation. In T3-treated microtissues, ATF6-associated ER-stress abnormalities include ER cisternal dilation and increased ATF6 signal. Targeted ATF6 knockdown reduces ATF6 signal, ER dilation, extracellular-matrix disorganization, and ER-stress/proteostasis and inflammatory/catabolic transcriptional module scores, supporting ATF6-associated signaling as a functionally relevant component of this degenerative state. In mouse temporomandibular joint and knee OA models, intra-articular Ad-shATF6 is associated with partial cartilage preservation and subchondral-bone indices shifted toward control ranges.
中文摘要:骨关节炎涉及软骨力学、基质成分和矿化的改变,但能解析重塑过渡的体外模型仍然有限。来源于人牙髓干细胞的人源无支架软骨微组织经过序贯动态摇摆培养和三碘甲状腺原氨酸处理。动态摇摆产生表层胶原I阳性的纤维化和基质降解变化,而三碘甲状腺原氨酸诱导蛋白聚糖丢失、胶原I和MMP13增加、不规则矿化沉积以及纳米力学性质改变,定义了一种混合的终末分解代谢和矿化骨关节炎样状态。转录组分析显示阶段相关的重组而非通路均匀激活。在三碘甲状腺原氨酸处理的微组织中,ATF6相关内质网应激异常包括内质网池扩张和ATF6信号增加。靶向敲低ATF6降低ATF6信号、内质网扩张、细胞外基质紊乱以及内质网应激/蛋白质稳态和炎症/分解代谢转录模块评分,支持ATF6相关信号作为该退变状态的功能性组成部分。在小鼠颞下颌关节和膝骨关节炎模型中,关节腔注射Ad-shATF6与部分软骨保留及亚软骨骨指数向对照组范围偏移相关。
Osteoarthritis (OA) progression is closely associated with the deterioration of joint lubrication. Although surface-grafted lubrication coatings can reduce friction, they are susceptible to mechanical damage under repetitive shear stress, resulting in rapid lubrication failure. Therefore, constructing a dynamically reconfigurable lubrication interface capable of continuous restoration under friction is critical for long-term joint protection. Herein, a dynamically self-repairing hydration lubrication microsphere system (HMs-CD@Ad-PMPC) is developed based on host-guest interactions. β-Cyclodextrin (β-CD)-functionalized silk fibroin microspheres dynamically recruit adamantane (Ad)-terminated poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) brushes through supramolecular host-guest recognition, thereby establishing a robust yet reversible hydration lubrication interface. Under shear stress during joint motion, partial dissociation of Ad-PMPC chains induces transient lubrication attenuation, while spontaneous molecular reassembly rapidly restores the lubrication interface upon stress release, thereby enabling dynamic self-repairing lubrication. In vitro, HMs-CD@Ad-PMPC maintains a stable low coefficient of friction (COF, 0.03-0.04) under cyclic shear conditions, exhibiting excellent wear resistance and long-term lubrication stability. In vivo, the system effectively reduces joint wear, preserves cartilage integrity, and significantly delays OA progression. This work establishes a dynamic lubrication strategy capable of restoring interfacial functionality under mechanical stress, providing a promising platform for long-term joint lubrication and OA therapy.
中文摘要:骨关节炎(OA)的进展与关节润滑功能的恶化密切相关。尽管表面接枝的润滑涂层可降低摩擦,但在重复剪切应力下易受机械损伤,导致润滑迅速失效。因此,构建在摩擦作用下具备持续修复能力的动态重构润滑界面对于长期保护关节至关重要。本研究开发了一种基于主客体相互作用的动态自修复水合润滑微球系统(HMs-CD@Ad-PMPC)。β-环糊精(β-CD)功能化的丝素蛋白微球通过超分子主客体识别动态招募金刚烷(Ad)末端的聚(2-甲基丙烯酰氧乙基磷酸胆碱)(PMPC)刷,从而建立坚固且可逆的水合润滑界面。在关节运动产生的剪切应力下,Ad-PMPC链的部分解离导致瞬时润滑衰减,而在应力释放后分子自发重组迅速恢复润滑界面,从而实现动态自修复润滑。体外实验表明,HMs-CD@Ad-PMPC在循环剪切条件下保持稳定的低摩擦系数(COF,0.03-0.04),表现出优异的耐磨性和长期润滑稳定性。体内实验显示,该系统有效减少关节磨损,维持软骨完整性,并显著延缓OA进展。本研究建立了一种在机械应力下可恢复界面功能的动态润滑策略,为长期关节润滑和OA治疗提供了有前景的平台。
2生物材料/植入物 (3篇)
基础研究 (3篇)
Interfacial hydration fundamentally constrains adhesion in aqueous and physiological environments by preventing intimate contact, competing for binding sites, and weakening the load-bearing interfaces. Although wet adhesives have been extensively designed for durable fixation, emerging technologies in soft robotics, wearable bioelectronics, and minimally invasive medicine require interfaces that can form adhesion, recover after reuse, or detach on-demand under hydrated conditions. This Review discusses reversible wet adhesion through two operational modes: Mode I, cyclic reusability through repeated restoration of adhesion over attachment-detachment cycles, and Mode II, on-demand detachability through trigger-induced conversion of a stable adhesive state into a weakly adherent state through a controlled, low-damage release pathway. We examine supramolecular interactions, dynamic covalent chemistry, mesoscale architectures, biomimetic designs, and hybrid strategies as complementary routes for regulating hydration, interfacial binding, mechanical dissipation, and adhesive state transitions at wet interfaces. We analyze how contact formation, hydration history, fracture pathways, loading history, test geometry, and biofluid exposure shape the measured performance. We further assess current methods for quantifying reusability, switching, durability, and biofluid tolerance, emphasizing failure mode-informed evaluation and standardized reporting criteria. Integrating hydration thermodynamics, binding kinetics, mechanical dissipation, and stimulus-gated interfacial transitions, this Review develops design and evaluation principles for reversible wet adhesive systems in complex aqueous and biointerfacial environments.
中文摘要:界面水合从根本上限制了水性和生理环境中的粘附性能,其通过阻止紧密接触、竞争结合位点以及削弱承载界面来发挥作用。尽管湿粘合剂已被广泛开发以实现持久固定,但软体机器人、可穿戴生物电子学和微创医学等新兴技术需要能够在湿润条件下形成粘附、重复使用后恢复或按需解离的界面。本综述通过两种操作模式探讨可逆湿粘附:模式I为循环可重复使用性,即通过附着-解离循环反复恢复粘附力;模式II为按需解离性,即通过触发诱导将稳定的粘合状态转化为弱粘合状态,实现受控的低损伤释放路径。我们考察了超分子相互作用、动态共价化学、介观结构、仿生设计及混合策略作为调节湿润界面处水合、界面结合、机械耗散及粘附状态转变的互补途径。我们分析了接触形成、水合历史、断裂路径、载荷历史、测试几何形状及生物流体暴露如何影响测量性能。进一步评估了当前量化可重复使用性、切换能力、耐久性及生物流体耐受性的方法,强调基于失效模式的评价和标准化报告准则。整合水合热力学、结合动力学、机械耗散及刺激门控界面转变,本综述构建了复杂水性和生物界面环境中可逆湿粘合系统的设计与评价原则。
Developing polymer gels that integrate high strength, stiffness, and toughness for impact protection remains challenging. Here, we present a synergistic molecular-structural design strategy to fabricate ultra-robust eutectogels by copolymerizing N-benzylacrylamide (BA) and acrylic acid (AA) in a deep eutectic solvent (DES) composed of choline chloride (ChCl) and glycerol (Gly). The contrasting solvent affinities of the two comonomers drive the spontaneous formation of a bicontinuous network, where the PBA-rich phase dissipates energy through hydrogen-bonded hydrophobic domains and the PAA-rich phase enables stress transfer and stretchability. The resulting gel achieves a fracture strength of 17.0 MPa, a modulus of 313.7 MPa, and a fracture toughness of 112.8 kJ m-2. Furthermore, the dynamic network imparts reliable self-recovery, self-healing, solvent-mediated reprocessability, and thermally promoted adhesion. The impact-protection performance is validated by falling-ball tests (yielding a 60% reduction in peak impact force) and the effective protection of fragile items. This molecular and structural engineering strategy is demonstrated to be generalizable to other miscible vinyl monomers and solvent systems, offering a promising solution to design robust polymer gels for next-generation soft protective materials.
中文摘要:开发兼具高强度、高刚度和高韧性的聚合物凝胶以实现冲击防护仍面临挑战。本研究提出一种协同分子结构策略,通过在由氯化胆碱和甘油组成的深共晶溶剂中共聚N-苄基丙烯酰胺和丙烯酸来制造超坚固的共晶凝胶。两种单体不同的溶剂亲和力驱动了双连续网络的自发形成,其中富含聚N-苄基丙烯酰胺的相通过氢键疏水结构域耗散能量,而富含聚丙烯酸的相实现应力传递和延展性。所得凝胶断裂强度为17.0 MPa,模量为313.7 MPa,断裂韧性为112.8 kJ m-2。此外,动态网络赋予其可靠的自恢复、自愈合、溶剂介导的可再加工性以及热促进的粘附性能。落球测试验证了其冲击防护性能(峰值冲击力降低60%)以及对易碎物品的有效保护。该分子与结构工程策略被证明可推广至其他混溶的乙烯基单体和溶剂体系,为设计用于下一代柔性防护材料的坚固聚合物凝胶提供了有前景的解决方案。
A sequential network-construction strategy is proposed for fabricating tough ionogels with phase-organized microstructures by introducing a flexible poly(methyl acrylate) (PMA) network into a relatively stiff poly(cyclohexyl acrylate) (PCHA) network, followed by the incorporation of an ionic liquid. Differences in monomer-polymer affinity, together with monomer penetration and swelling of the preformed PCHA network and subsequent polymerization-induced compositional evolution, promote the formation of a microphase-separated, bicontinuous network structure. Within this phase-organized architecture, the interconnected polymer networks facilitate efficient load transfer and mechanical energy dissipation, while the compliant network components accommodate large deformations and maintain high stretchability. The combined effects of network interpenetration, chain entanglement, and intermolecular interactions therefore contribute to the enhanced mechanical robustness. As a result, the resulting ionogels display outstanding mechanical performance, including a high fracture strength of ∼21.3 MPa, an exceptional toughness of ∼3500 J m-2, and a Young's modulus of ∼6.5 MPa. Notably, the evolution of the bicontinuous phase under large deformation is clearly revealed by in situ small-angle X-ray scattering (SAXS) analysis in conjunction with coarse-grained simulations of network evolution dynamics. Ionogels prepared through polymer chains entanglement exhibit outstanding fatigue resistance, as evidenced by a residual strain of only ∼1% after 100 loading-unloading cycles over a strain range of 0-12%, together with rapid recovery to their original configuration within 5 s. Our results suggest that appropriately tuning monomer-polymer affinity, monomer penetration and swelling, and polymerization-induced compositional evolution may provide a viable route for constructing bicontinuous network structures in hybrid polymer/ionic-liquid systems.
中文摘要:提出了一种顺序构建网络策略,通过将柔性聚甲基丙烯酸甲酯(PMA)网络引入相对刚性的聚环己基丙烯酸酯(PCHA)网络并随后掺入离子液体,制备具有相组织微结构的坚韧离子凝胶。单体与聚合物亲和力的差异以及预形成PCHA网络的单体渗透和溶胀及随后的聚合诱导组分演变促进了双连续微相分离网络结构的形成。在该相组织结构中,相互连接的网络促进有效的载荷传递和机械能耗散,而柔性网络组件适应大变形并保持高延展性。网络互穿、链缠结和分子间相互作用的共同作用增强了机械鲁棒性。因此,所得离子凝胶表现出优异的机械性能,包括约21.3 MPa的高断裂强度、约3500 J m-2的卓越韧性以及约6.5 MPa的杨氏模量。值得注意的是,原位小角X射线散射(SAXS)分析与网络演变动力学的粗粒度模拟相结合清晰地揭示了大变形下双连续相的演变。通过聚合物链缠结构备的离子凝胶表现出优异的抗疲劳性,在0-12%应变范围内的100次加载卸载循环后残余应变仅为约1%,并在5秒内快速恢复至原始构型。研究结果表明,适当调节单体与聚合物亲和力、单体渗透和溶胀以及聚合诱导组分演变可能为构建杂化聚合物离子液体体系中的双连续网络结构提供可行途径。
3感染/假体周围感染 (1篇)
基础研究 (1篇)
Bone infection is a common and serious complication in orthopedic surgery. Conventional antibiotic strategies frequently induce antibiotic resistance, leading to the persistence of bone infections. In this study, an engineered peptide nanoparticle named C8-IK21 was designed based on the coiled-coil motif. Specifically, C8-IK21 effectively targeted bacterial cell membranes, further exacerbating bacterial death through lipid peroxidation. At safe doses, local administration of C8-IK21 demonstrated high efficacy in treating S. aureus-infected cortical bone defects in mice. No detectable resistance emerged under the tested experimental conditions. Additionally, C8-IK21 exhibited anti-inflammatory activity. Furthermore, C8-IK21 could enter cells by binding to ADAM9, activating the ERK signaling pathway to regulate osteoblast differentiation. Meanwhile, C8-IK21 reduced the expression of ITGB1 via ADAM9, thereby inhibiting osteoclast differentiation and function. Moreover, the pro-osteogenic effect of C8-IK21 was validated in organoids. In conclusion, C8-IK21 represents a promising therapeutic approach for the treatment of refractory bacterial infections and bone homeostasis disorders.
中文摘要:骨感染是骨科手术中常见且严重的并发症。传统抗生素策略常诱导耐药性,导致骨感染迁延不愈。本研究设计了一种基于卷曲螺旋基序的工程化肽纳米颗粒C8-IK21。具体而言,C8-IK21能有效靶向细菌细胞膜,并通过脂质过氧化进一步加剧细菌死亡。在安全剂量下,局部给药C8-IK21在小鼠金黄色葡萄球菌感染的皮质骨缺损模型中显示出高效的治疗效果。在测试的实验条件下未检测到耐药性产生。此外,C8-IK21表现出抗炎活性。同时,C8-IK21通过与ADAM9结合进入细胞,激活ERK信号通路以调节成骨细胞分化。另一方面,C8-IK21通过ADAM9降低ITGB1的表达,从而抑制破骨细胞的分化和功能。此外,C8-IK21的促骨生成作用在类器官中得到验证。综上所述,C8-IK21代表了治疗难治性细菌感染和骨稳态紊乱的一种有前景的治疗策略。
4关节置换 (1篇)
临床研究 (1篇)
The direct anterior approach (DAA) for THA is seeing wider use because it is purported to deliver a faster postoperative recovery. However, most previous studies comparing the DAA with the posterolateral approach (PLA) were limited by small sample sizes, heterogeneous patient populations, and the use of outcome measures with ceiling effects. (1) Does the DAA result in a higher proportion of patients achieving the patient acceptable symptom state (PASS) on the Hip Disability and Osteoarthritis Outcome Score (HOOS) after THA compared with the PLA? (2) Are there differences in symptoms, physical function, life activities and participation, health-related quality of life (QoL), or complications between the DAA and PLA in the first postoperative year? A prospective, parallel-group, nonblinded, randomized controlled trial comparing the DAA and PLA for THA was conducted. Patients with primary or secondary osteoarthritis with an indication for THA with an uncemented femoral stem and cemented acetabular component were eligible. Of the 241 patients assessed for eligibility, 53% (128) were included in the study. Fifty-one percent (65 of 128) were randomized to the DAA group, and 49% (63 of 128) were randomized to the PLA group. One patient in each group was lost to follow-up, leaving 98% (64 of 65) and 98% (62 of 63) of patients available for analysis, respectively. There were no between-group differences in baseline or perioperative measurements. The primary outcome was achievement of the PASS on the HOOS at 3 months postoperatively. An a priori sample-size calculation indicated that 60 patients per group were required to detect a 20% difference in PASS achievement between groups (80% power; α = 0.05). With an expected loss to follow-up of 10%, the sample size was set to 65 patients per group. Secondary outcomes included symptoms, physical functioning, participation, and health-related QoL, assessed using patient-reported outcome measures and physical performance tests. Complications were assessed using the Clavien-Dindo classification. Outcomes were assessed preoperatively as well as at 2 weeks, 6 weeks, 3 months, and 1 year postoperatively. At 3 months, the proportion of patients achieving the PASS did not differ between the DAA and PLA for any HOOS subscales, including symptoms (65% [41 of 63] versus 63% [39 of 62], OR 1.03 [95% confidence interval (CI) 0.80 to 1.35]; p = 0.80), pain (48% [30 of 63] versus 53% [33 of 62], OR 0.90 [95% CI 0.63 to 1.27]; p = 0.53), activities of daily living (68% [43 of 63] versus 65% [40 of 62], OR 1.06 [95% CI 0.82 to 1.36]; p = 0.66), sports and recreation (55% [34 of 62] versus 58% [36 of 62], OR 0.94 [95% CI 0.69 to 1.29]; p = 0.72), and QoL (73% [46 of 63] versus 71% [44 of 62], OR 1.03 [95% CI 0.83 to 1.28]; p = 0.80). There were no between-group differences in symptoms, physical function, life activities and participation, and health-related QoL at any time point. Complications occurred in 8% (5 of 65) of patients in the DAA group and 2% (1 of 63) of patients in the PLA group (OR 3.05 [95% CI 0.51 to 18.40]; p = 0.21). In this randomized controlled trial, the DAA did not improve patient-reported or functional outcomes compared with the PLA during the first postoperative year. In the absence of demonstrated patient-reported or functional benefits of the DAA, surgeons should not represent to patients that the DAA provides advantages in terms of the pace or magnitude of recovery. Future studies powered to detect differences in the risk of complications should be performed to see whether harms are more likely with the DAA than with other surgical approaches. Level I, therapeutic study.
中文摘要:全髋关节置换术(THA)的直接前方入路(DAA)因声称能带来更快的术后恢复而得到更广泛的应用。然而,以往比较DAA与后外侧入路(PLA)的研究多受限于样本量小、患者人群异质性以及使用存在天花板效应的结局指标。本研究旨在探讨:(1)THA后DAA组达到髋关节残疾和骨关节炎评分(HOOS)患者可接受症状状态(PASS)的患者比例是否高于PLA组?(2)在术后第一年,两组在症状、躯体功能、生活活动与参与、健康相关生活质量(QoL)或并发症方面是否存在差异?本研究是一项前瞻性、平行组、非盲法随机对照试验,比较THA的DAA与PLA。入选标准为患有原发性或继发性骨关节炎且具备使用未涂层股骨柄和水泥型髋臼假体进行THA指征的患者。在评估资格的241名患者中,53%(128名)纳入研究。其中51%(65/128)随机分配至DAA组,49%(63/128)随机分配至PLA组。每组各有一名患者失访,最终分别有98%(64/65)和98%(62/63)的患者可用于分析。两组基线及围手术期测量值无差异。主要结局为术后3个月HOOS达到PASS的比例。先验样本量计算显示,每组需60名患者以检测组间PASS达成率20%的差异(效能80%,α=0.05)。考虑到10%的预期失访率,每组样本量设定为65名。次要结局包括使用患者报告结局测量工具和躯体功能测试评估的症状、躯体功能、参与情况及健康相关QoL。并发症采用Clavien-Dindo分级进行评估。结局指标在术前及术后2周、6周、3个月和1年时进行评估。术后3个月时,DAA与PLA组在各HOOS子量表达到PASS的患者比例无差异,包括症状(65% [41/63] vs 63% [39/62],OR 1.03 [95% CI 0.80至1.35];p=0.80)、疼痛(48% [30/63] vs 53% [33/62],OR 0.90 [95% CI 0.63至1.27];p=0.53)、日常生活活动(68% [43/63] vs 65% [40/62],OR 1.06 [95% CI 0.82至1.36];p=0.66)、运动与娱乐(55% [34/62] vs 58% [36/62],OR 0.94 [95% CI 0.69至1.29];p=0.72)以及QoL(73% [46/63] vs 71% [44/62],OR 1.03 [95% CI 0.83至1.28];p=0.80)。在任何时间点,两组在症状、躯体功能、生活活动与参与以及健康相关QoL方面均无差异。DAA组并发症发生率为8%(5/65),PLA组为2%(1/63)(OR 3.05 [95% CI 0.51至18.40];p=0.21)。在本随机对照试验中,与PLA相比,DAA在术后第一年内并未改善患者报告或功能结局。鉴于未证实DAA在患者报告或功能方面具有优势,外科医生不应向患者宣称DAA在恢复速度或幅度上具有优势。未来应开展旨在检测并发症风险差异的研究,以明确DAA是否比其他手术入路更可能导致伤害。I级治疗性研究。
5创伤骨科 (1篇)
基础研究 (1篇)
Starch content serves as a pivotal indicator for evaluating the quality of liquor fermented grains (LFG). Nevertheless, on-site starch quantification in LFG remains a bottleneck for solid-state fermentation monitoring, restricted by cumbersome Fehling's titration and costly near-infrared spectrometers requiring complex modeling. In this work, a tri-modal sensing platform based on a biomass-derived nanozyme/H2O2/TMB cascade system was constructed for visual indirect starch quantification in LFG. Starch was hydrolyzed following standard DB 34/T 2264-2014, and the resulting hydrolysate was used for starch quantification. Peroxidase-like Fe-doped lignin-derived carbon dots (Fe-LCDs) were synthesized from lignin extracted from waste distillers' spent grains (DG) via deep eutectic solvent (DES). Fe-LCDs and 3,3',5,5'-Tetramethylbenzidine (TMB) were integrated into a portable breakable cotton swab (Fe-LCDs/TMB@BCS) sensor with separated compartments for stable reagent storage. Swab fracture initiates reagent mixing to produce colorimetric, fluorescent and photothermal signals toward glucose, with LODs of 1.86, 1.67 and 2.15 μM, respectively. Notably, compared with 2 h and 1 h required by conventional Fehling's titration and near-infrared spectroscopy to analyze 100 samples, the Fe-LCDs/TMB@BCS sensor enables parallel signal readout for 100 samples within 10 min (excluding the mandatory acid-hydrolysis pretreatment). This facile and efficient sensor advances on-site quality control for baijiu solid fermentation and holds potential for broader applications in food fermentation.
中文摘要:淀粉含量是评估白酒发酵粮(LFG)质量的关键指标。然而,现场淀粉定量仍是固态发酵监测的瓶颈,受限于繁琐的斐林滴定法和需要复杂建模且昂贵的近红外光谱仪。本研究构建了一种基于生物质衍生纳米酶/H2O2/TMB级联系统的三模传感平台,用于LFG中淀粉的视觉间接定量。按照标准DB 34/T 2264-2014水解淀粉,利用所得水解液进行淀粉定量。通过深共晶溶剂(DES)从废酒糟(DG)中提取木质素,合成了具有过氧化物酶活性的铁掺杂木质素衍生碳点(Fe-LCDs)。将Fe-LCDs和3,3',5,5'-四甲基联苯胺(TMB)集成到带有独立隔室的便携式可折断棉签(Fe-LCDs/TMB@BCS)传感器中,以实现试剂的稳定储存。折断棉签启动试剂混合,针对葡萄糖产生比色、荧光和光热信号,检出限分别为1.86、1.67和2.15μM。值得注意的是,与传统斐林滴定法(2小时)和近红外光谱法(1小时)分析100个样本相比,Fe-LCDs/TMB@BCS传感器可在10分钟内完成100个样本的并行信号读取(不包括强制性的酸水解预处理)。这种简便高效的传感器推动了白酒固态发酵的现场质量控制,并有望在食品发酵领域有更广泛的应用。
6骨质疏松/骨代谢 (1篇)
基础研究 (1篇)
Osteoclastogenesis requires precise coordination between mitochondrial bioenergetics and anabolic programs, yet the underlying mechanisms remain unclear. Here, we identify the mitochondrial citrate carrier (CIC, encoded by SLC25A1) as a crucial link that couples mitochondrial bioenergetics to glutathione (GSH)-dependent redox regulation during osteoclastogenesis. CIC expression was elevated in the osteoclast-lineage cells from postmenopausal osteoporosis (PMOP) patients and ovariectomized (OVX) mice, and was positively correlated with classical osteoclast markers. During osteoclastogenesis, CIC was progressively upregulated. Pharmacologic inhibition of CIC with CTPI-2 not only suppressed osteoclastogenesis but also disrupted core metabolic processes, including tricarboxylic acid cycle engagement, amino acid biosynthesis, and mitochondrial respiration. Integrative transcriptomic and metabolomic profiling further revealed a compensatory shift toward enhanced GSH synthesis. Mechanistically, CIC associated with the glutamate-cysteine ligase modifier subunit (GCLM), linking mitochondrial metabolic regulation to the GSH synthetic machinery. CIC inhibition increased GCL activity, intracellular GSH content, and the GSH/GSSG ratio, accompanied by reduced reactive oxygen species accumulation. The functional importance of the GSH axis was evident, as GCL inhibition by buthionine sulfoximine partially reversed the anti-osteoclastogenic effects of CIC inhibition. Consistently, osteoclast-targeted silencing of CIC in OVX mice mitigated bone loss. Collectively, these findings support a role for CIC as a metabolic integrator of energy and redox metabolism in osteoclasts, and highlight its potential as a candidate target for limiting excessive bone resorption in PMOP.
中文摘要:破骨细胞生成需要线粒体生物能量代谢与合成代谢程序之间的精确协调,但其潜在机制尚不清楚。本研究鉴定出线粒体柠檬酸载体(CIC,由SLC25A1编码)是连接破骨细胞生成过程中线粒体生物能量代谢与谷胱甘肽(GSH)依赖性氧化还原调节的关键纽带。在绝经后骨质疏松症(PMOP)患者的破骨细胞谱系细胞及卵巢切除(OVX)小鼠中,CIC表达升高,且与经典破骨细胞标志物呈正相关。在破骨细胞生成过程中,CIC逐渐上调。药理学抑制CIC不仅抑制了破骨细胞生成,还破坏了核心代谢过程,包括三羧酸循环参与、氨基酸生物合成及线粒体呼吸。整合转录组和代谢组分析进一步揭示了一种向增强GSH合成的代偿性转变。机制上,CIC与谷氨酸半胱氨酸连接酶修饰亚基(GCLM)结合,将线粒体代谢调节与GSH合成机器联系起来。抑制CIC增加了GCL活性、细胞内GSH含量及GSH/GSSG比值,并伴随活性氧积累减少。GSH轴的功能重要性显而易见,因为使用丁硫氨酸亚砜胺抑制GCL部分逆转了抑制CIC的抗破骨细胞生成作用。一致地,在OVX小鼠中靶向沉默破骨细胞中的CIC减轻了骨质流失。综上所述,这些发现支持CIC作为破骨细胞能量和氧化还原代谢整合因子的作用,并突显其作为限制PMOP过度骨吸收候选靶点的潜力。